Insider · CIK 0001201050

TOOMAN CRAIG A

Reports to the SEC for 5 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001201050

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-02	SLNSilence Therapeutics plc · Employee Share Option (Right to Buy)A Award	Director, President and CEO	AAward	+900K sh	—	—	900,000
2019-07-18	ARATANA THERAPEUTICS, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−308K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−222K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−60K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−45K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−57.5K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−32.5K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−25K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−90.5K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−6,016 sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−15K sh	—	—	0
2019-01-24	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+222K sh	—	—	222,222
2019-01-24	ARATANA THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−18.5K sh	$4.22	−$78K	307,501
2019-01-24	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+211K sh	—	—	325,991
2018-01-25	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+60K sh	—	—	60,000
2018-01-25	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+39.7K sh	—	—	114,724
2017-12-21	ARATANA THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,000 sh	$3.14	+$6,280	105,024
2017-12-21	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,000 sh	—	—	55,500
2017-01-13	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+45K sh	—	—	45,000
2017-01-13	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+30.6K sh	—	—	103,024
2016-09-09	ARATANA THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−30K sh	$9.25	−$278K	72,424
2016-02-01	ARATANA THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,806 sh	$3.36	−$9,436.017	102,424
2016-01-22	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+35.3K sh	—	—	105,230
2016-01-22	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+57.5K sh	—	—	57,500
2015-11-09	ARATANA THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−3,620 sh	$7.52	−$27.2K	69,980
2015-11-02	INSITE VISION INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−43.8K sh	—	—	0
2015-11-02	INSITE VISION INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	$0.35	−$52.5K	0
2015-11-02	INSITE VISION INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	$0.35	−$52.5K	0
2015-11-02	INSITE VISION INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	$0.35	−$52.5K	0
2015-11-02	INSITE VISION INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−150K sh	—	—	0
2015-10-02	ARATANA THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−3,250 sh	$8.06	−$26.2K	73,600
2015-01-29	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+32.5K sh	—	—	32,500
2015-01-29	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+22.3K sh	—	—	76,850
2014-12-10	INSITE VISION INCStock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2014-10-01	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+10K sh	—	—	54,550
2014-01-13	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+25K sh	—	—	25,000
2013-12-11	INSITE VISION INCStock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2013-11-08	ARATANA THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+44.6K sh	—	—	44,550
2013-11-08	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+90.5K sh	—	—	90,450
2012-12-12	INSITE VISION INCStock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2011-12-14	INSITE VISION INCStock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2011-09-16	INSITE VISION INCEmployee Stock Option (Right to Buy)A Award	Director	AAward	+43.8K sh	—	—	43,750
2010-06-18	ENZNViskase Holdings, Inc.M Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	+141K sh	$8.59	+$1.21M	283,580
2010-06-18	ENZNViskase Holdings, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	−141K sh	—	—	159,200
2010-06-18	ENZNViskase Holdings, Inc.S Sale	Exec VP Finance, CFO	SSale	−123K sh	$11.25	−$1.39M	160,480
2010-05-12	ENZNViskase Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	−6,000 sh	—	—	0
2010-05-12	ENZNViskase Holdings, Inc.F Tax Payment	Exec VP Finance, CFO	FTax Payment	−2,126 sh	$10.90	−$23.2K	142,780
2010-05-12	ENZNViskase Holdings, Inc.M Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	+6,000 sh	—	—	144,906
2010-04-03	ENZNViskase Holdings, Inc.M Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	+16.7K sh	—	—	144,836
2010-04-03	ENZNViskase Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Exec VP Finance, CFO	MExercise/Conversion	−16.7K sh	—	—	22,320

Recent filings

Accepted (ET)
Jan 64
TOOMAN CRAIG A0001415889-25-000743
SEC(opens sec.gov)
Jul 184
TOOMAN CRAIG A0001209191-19-042725
SEC(opens sec.gov)
Jan 284
TOOMAN CRAIG A0001209191-19-005622
SEC(opens sec.gov)
Jan 264
TOOMAN CRAIG A0001209191-18-005660
SEC(opens sec.gov)
Dec 214
TOOMAN CRAIG A0001209191-17-066860
SEC(opens sec.gov)
Jan 174
ARATANA THERAPEUTICS, INC.0001209191-17-003952
SEC(opens sec.gov)

Companies

Address

C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206

BRIDGEWATER, NJ, 08807